Literature DB >> 12193556

A 77-base pair LINE-like sequence elicits androgen-dependent mvdp/akr1-b7 expression in mouse vas deferens, but is dispensable for adrenal expression in rats.

Pierre Val1, Antoine Martinez, Isabelle Sahut-Barnola, Claude Jean, Georges Veyssière, Anne-Marie Lefrançois-Martinez.   

Abstract

Mvdp/akr1-b7 (mouse vas deferens protein/aldo-keto reductase 1-B7) encodes an enzyme responsible for detoxification of a steroidogenesis byproduct. MVDP/AKR1-B7 is expressed in both rat and mouse adrenal cortex under ACTH control, whereas strong androgen-dependent accumulation in the vas deferens is mouse specific. Comparison of the regulatory regions of the two orthologs reveals a strong identity, disrupted by acquisition of a 77-bp LINE-derived sequence in the mouse promoter. Although ACTH responsiveness is observed in both species, the absence of this 77-bp sequence in the rat is associated with changes in transcription initiation sites. Transfection studies demonstrate that the CCAAT/enhancer-binding protein and selective promoter factor 1-binding sites previously shown to be essential for cAMP/ACTH induction in the mouse are consequently dispensable in the rat. Our data support the idea that the most striking change generated by this acquisition is the strong, androgen-dependent, vas deferens expression observed in mouse. 1) In rat vas deferens, rakr1-b7 expression is barely detectable and is not androgen sensitive. 2) Androgen receptor binds efficiently to an androgen response element within the 77-bp mouse-specific element. 3) Its insertion confers androgen sensitiveness to rakr1-b7 regulatory regions in an androgen response element-dependent manner in transient transfections. We propose that this acquired androgen-responsive region may be responsible for vas deferens androgen-regulated gene expression in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193556     DOI: 10.1210/en.2002-220293

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Structure of the His269Arg mutant of the rat aldose reductase-like protein AKR1B14 complexed with NADPH.

Authors:  Krithika Sundaram; Satoshi Endo; Toshiyuki Matsunaga; Nobutada Tanaka; Akira Hara; Ossama El-Kabbani
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-03-27

3.  Crystallization and preliminary X-ray analysis of a rat aldose reductase-like protein (AKR1B14).

Authors:  Roland Chung; Satoshi Endo; Akira Hara; Ossama El-Kabbani
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-03-25

4.  Aldo-Keto Reductases 1B in Endocrinology and Metabolism.

Authors:  Emilie Pastel; Jean-Christophe Pointud; Fanny Volat; Antoine Martinez; Anne-Marie Lefrançois-Martinez
Journal:  Front Pharmacol       Date:  2012-08-02       Impact factor: 5.810

5.  AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids.

Authors:  Daniel R Schmidt; Samuel Schmidt; Sam R Holmstrom; Makoto Makishima; Ruth T Yu; Carolyn L Cummins; David J Mangelsdorf; Steven A Kliewer
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

6.  Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.

Authors:  Sarah Lambert-Langlais; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Fanny Volat; Michèle Manin; François Coudoré; Pierre Val; Isabelle Sahut-Barnola; Bruno Ragazzon; Estelle Louiset; Catherine Delarue; Hervé Lefebvre; Yoshihiro Urade; Antoine Martinez
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.